• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Ependymoma

Ependymoma - 48 Studies Found

Terminated : Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Ependymoma
  • <
    : 2007-01-30
    :
    • Drug: etanidazole Given IV

Terminated : Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Ependymoma
  • <
    : 2005-05-03
    :
    • Drug: EF5 Given IV

Completed : Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Ependymoma
  • <
    : 2002-02-14
    :
    • Drug: erlotinib hydrochloride

Terminated : Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
:
  • Adult Anaplastic (Malignant) Meningioma
  • Adult Anaplastic Astrocytoma
  • Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Terminated : Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
: Ependymoma
: 2010-03-16
: Drug: Carboplatin Patients will receive daily carboplatin as a radiation sensitizer prior to radiation e
Completed : A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
: Ependymoma
: 2014-04-25
:
  • Radiation: Irradiation Radiati

Completed : Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod
: Ependymoma
: 2013-02-12
:
  • Biological: HLA-A2 restricted synthetic tumor antigen

Completed : An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma
: Childhood Ependymoma
: 2014-09-29
:
  • Drug: 16 weeks of VEC + CDDP D

Terminated : Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma
: Recurrent or Refractory Pediatric Ependymoma
: 2009-12-10
:
  • Drug: erlotinib oral

Recruiting : Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma
: Posterior Fossa Ependymoma (PFEPN)
: 2016-05-06
:
  • Drug: Trastuzumab after SubQ GM-CSF
  • Drug:

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.